版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
SummaryofClinicalDiseasesSubject:Alzheimer'sdisease职业教育康复治疗技术专业教学资源库《临床疾病概要》1Definition,etiopathology2Symptoms,signs,anddiagnosis3Treatmentprinciples,healtheducation目录康复治疗技术专业教学资源库1.1Alzheimer'sdisease(Alzheimer'sdisease,AD)Alsoknownasseniledementia.Itisadegenerationdiseaseofthecentralnervoussystemcharacterizedbymemorylossandcognitivedysfunction.Andaccompaniedbyavarietyofmentalandbehavioralsymptoms.Alzheimer'sdisease康复治疗技术专业教学资源库1.1
TheonsetofADisinsidiousanddelayedtreatmentcanappearprogressiveaggravation.
Withthecontinuousprogressofthedisease,patientsgraduallylosetheabilitytotakecareofthemselves,andcompletelyrelyonothersinthelatedailylife,whichcausesahugeburdenonpatientsthemselves,theirfamiliesandsociety.Alzheimer'sdisease康复治疗技术专业教学资源库1.1epidemiology:TheprevalenceofADhasincreasedyearbyyear.Accordingtothesurvey,by2020,theprevalenceofADpatientsovertheageof60inChinareached3.94%,withatotalof9.83millionADpatients,accountingfor65.23%ofallpatientswithdementia[1,2]。Alzheimer'sdisease[1]JiaL,DuY,JiaJP,etal.Prevalence,riskfactors,andmanagementofdementiaandmildcognitiveimpairmentinadultsaged60yearsorol_x0002_derinChina:across-sectionalstudy[J].LancetPublicHealth,2020,5(12):e661-e671.[2]JiaL,QuanM,JiaJP,etal.DementiainChina:epidemiology,clini_x0002_calmanagement,andresearchadvances[J].LancetNeurol,2020,19(1):81-92.康复治疗技术专业教学资源库1.2◎βAmyloidhypothesisandevolution.◎Tauproteinhypothesisandevolution.◎AβinsynergywithTauproteininADpathogenesis.◎Excitotoxicityhypothesis(glutamateexcitotoxicityisoneofthemoreclassicpathologiesofAD).◎Oxidativestresshypothesis.◎Theoestrogenhypothesis.ThepathogenesisofAD康复治疗技术专业教学资源库1.2◎Geneticandriskfactors:1.
Genemutations.2.Riskfactors:Vascularriskfactorsincludehypertension,diabetesmellitus,dyslipidemia,overweightorobesity,smokingorharmfulalcoholconsumption,andcardiovascularandcerebrovasculardiseases.Peoplewithdepressivedisordersandsleepdisorders.ThepathogenesisofAD康复治疗技术专业教学资源库1.3PathologyofADMajorpathologicalfindingsinclude:◎encephalanalosis◎senileplaquesformedbycerebralamyloiddeposits(senileplaque,SP)◎
neurofibrillarytangles(neurofibrillarytangles,NFTs)◎reduced
synapses◎degenerationanddeathoftheneurons.康复治疗技术专业教学资源库1.3PathologyofADMainlesionsite:
Hippocampalsitesaremostcommonlyinvolved.Parietalandfrontallobeatrophy.康复治疗技术专业教学资源库Case
Thepatient,male,was65yearsold.Memorydeclinedformorethan1year,theperformanceoftherecentmemorydeclined,buthecanrecognizethewayhome.Hequicklyforgotwhathejustsaidorforgotwheretoputtheitems.Thismonthheappearedgrumpy,likedtocurse.Poorsleepatnight.Physicalexamination:clearconsciousness.Thereactionwasslightlyslow,theanswerwasnormal,computationalpowerdecreased.1.Howisthepatient’sdiagnosis?2.Whatinspectionneedtobeimproved?康复治疗技术专业教学资源库2.1Alzheimer'sdisease(Alzheimer'sdisease,AD)Itsmainclinicalmanifestationisthelastingandcomprehensivedeclineofmemoryandcognitivefunction.Clinicalfeaturesareinsidiousonset,progressiveintelligenceloss,andmanyassociatedwithpersonalitychanges.SymptomsofADClinicalsymptoms:memoryimpairment,cognitiveimpairment,andmentalsymptoms.康复治疗技术专业教学资源库2.2SignsofAlzheimer'sdisease(assessment)Scaleevaluation:theMMSEscale,theMOCAscale康复治疗技术专业教学资源库2.2SignsofAlzheimer'sdisease(assessment)MMSE:
Itisoneofthemostcommonlyusedscreeningtoolsforcognitiveimpairmentintheworld.Thereare30itemsinthescale,includingmemory,attention,orientation,language,executionandsoon.Participantsneedtocompleteproblemssuchasyear,month,100minus7,anddrawing,withscoresbetween0and30.Thelowerthescore,theheavierthecognitivedamage,and3isthesignificantdifference.Thecut-offvalueofcognitiveimpairmentdeterminedbyeducationlevelwas17pointsforilliteracy(noeducation),20pointsforprimaryschoolgroup(6yearsofeducation),and24pointsformiddleschoolandabovegroup(yearsofeducation>6years).Scaleassessment康复治疗技术专业教学资源库康复治疗技术专业教学资源库2.2SignsofAlzheimer'sdisease(assessment)
DevelopedbyNasreddineetal.basedonclinicalexperienceandreferringtotheMMSE,thefinalversionwasdeterminedinNovember2004andisaratingtoolforrapidscreeningofcognitivefunctionabnormalities.Itincludes11inspectionitemsin8cognitivedomainsincludingattention,concentration,executivefunction,memory,language,visualstructureskills,abstractthinking,computationanddirectionalforce.Thetotalscoreis30,and
≥26isnormal,withhighsensitivity,coveringimportantcognitiveareas,shorttesttimeandsuitableforclinicaluse.However,itisalsoaffectedbytheeducationallevel,thedifferencesinculturalbackground,theskillsandexperienceofMoCAusedbytheexaminer,theenvironmentandtheemotionalandmentalstateofthesubjectswillallaffectthescore.Itismoresensitivetothescreeningofmildcognitivedysfunction(MIC).Scaleassessment康复治疗技术专业教学资源库MoCA:康复治疗技术专业教学资源库2.2SignsofAlzheimer'sdisease(assessment)Scaleassessment:康复治疗技术专业教学资源库2.2Alzheimer'sdiseasediagnosisclinlcalsymptomImagingfindingsPathologicalmanifestationsAlzheimerdiseaseHiddenonset,continuousprogressiveintelligencedecline,memory,cognitiveimpairmentwithmentalsymptomsencephalanalosissenileplaques,neuronalfibrillarytangles,granularvacuolardegenerationofhippocampalpyramidalcells,andneuronallossFronto-temporaldementia(pickdisease)Personalityandmentaldisordersappearearly;forgettingappearslaterFrontalandtemporallobebrainatrophySilver-stainedintracytoplasmicinclusions(pickbodies)appearedintheneuralcellsoftheneocortexandhippocampusvasculardementiaAcuteorsubacuteonsetofsymptomswithsignsofneurologicallocalization.Mainlymanifestatedbyexecutivedysfunction.MultiplelesionsofcerebrovasculardiseaseFocalordiffuseischemicbrainwhitematterlesions.LouiebodydementiaVolatifluctuatingcognitiveimpairment,repeatedvisualhallucinations,andspontaneousextrapyramidaldysfunctionWhole-brainatrophy,enlargedventricles,andwhitematterdegenerationLewybodies:spherical,erosmophilicinclusionsinthecytoplasmofneurons.Clinicaldifferentialdiagnosisofvariousdementias康复治疗技术专业教学资源库3.1PrinciplesofADtreatment康复治疗技术专业教学资源库drugsnon-drugtherapy3.11.
cholinergicsystemdrugs:tacrine,donepezil,carbabatinandgalantamine.2.NMDAreceptorantagonist:easytimesapplication.
Onlyatransientimprovementofpatients'cognitivesymptoms,butcannotreversethediseaseprocessPrinciplesofADtreatment康复治疗技术专业教学资源库drugs3.1PrinciplesofADtreatmentNovelanti-ADdrugs:AβtargetsSolanezumab:Sorizumab;Gantenerumab:GengLucumab;Aducanumab:Adunatumab;Crenezumab:Kremonomab;Lecanemab:Lenainecumab;Donanemab:Donecumab.康复治疗技术专业教学资源库drugs3.1PrinciplesofADtreatmentNovelanti-ADdrug:Tau,aproteintargetSemorinemab:Seronumab;Bepranemab:Benonumab康复治疗技术专业教学资源库drugs3.1PrinciplesofADtreatmentθTargetofneuroinflammationθBrainmetabolictargets康复治疗技术专业教学资源库drugs3.1PrinciplesofADtreatmentCognitiveintervention:cognitivestimulation,cognitiverehabilitation,andcognitivetrainingReality-orientedtherapyNostalgiatherapymethodMultisensorytherapymusicaltherapy康复治疗技术专业教学资源库non-drugtherapy3.1PrinciplesofADtreatmentNostalgiatreatmentmethodMultisensorytherapy康复治疗技术专业教学资源库non-drugtherapy3.1PrinciplesofADtreatment康复治疗技术专业教学资源库non-drugtherapy3.1PrinciplesofADtreatmentDietaryregulation:supplementvitamins,traceelementsandothernutrients.aerobicexercise.Non-invasivebrainstimulationtechnologycurrentlyusetranscranialmagneticstimulation(transcranialmagneticstimulation,TMS),transcranialdirectcurrentstimulation(transcranialdirectcurrentstimulation,tDCS)technologyandγ-frequencysensorystimulation.康复治疗技术专业教学资源库non-drugtherapy3.2AD'sHealthEducationandPreventio
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 护理礼仪的护理查房
- 护理团队建设与协作能力
- 浙江省嘉兴市经开区2023-2024学年四年级下学期语文期末试卷(含答案)
- 护理职业安全与防护课件
- 2026深意的面试题及答案
- 2026石狮语文面试题目分析及答案
- 2026市监总局面试题及答案
- 2026手术供应室面试题及答案
- 2026水利厅机械面试题及答案
- 2026思春烟草面试题及答案
- 2026中智信通科技服务(广东)有限公司招聘笔试历年常考点试题专练附带答案详解
- 2026江苏南京紫金投资集团有限责任公司社会化招聘笔试历年参考题库附带答案详解
- 2026年轻型民用无人驾驶航空器安全操控(多旋翼)理论备考试题及答案
- 中国建筑二测考试题库
- 注塑车间装模培训
- MTT 146-2025 树脂锚杆标准
- 学校围墙劳务合同范本
- 货代角色扮演培训大纲
- 2025年《税收征收管理法》新修订版知识考试题库及答案解析
- 租房装修民宿合同范本
- T∕FDSA 0100-2025 抗衰老医学门诊设置基本要求
评论
0/150
提交评论